Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The Structure of Clinical Translation: Efficiency, Information, and EthicsThe Hastings Center report, 2015-03, Vol.45 (2), p.27-39 [Peer Reviewed Journal]2015 The Hastings Center ;Copyright Blackwell Publishing Ltd. Mar-Apr 2015 ;ISSN: 0093-0334 ;EISSN: 1552-146X ;DOI: 10.1002/hast.433 ;PMID: 25628068 ;CODEN: HSCRASFull text available |
|
2 |
Material Type: Article
|
Knowledge translation in health: how implementation science could contribute moreBMC medicine, 2019-05, Vol.17 (1), p.88-88, Article 88 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-019-1322-9 ;PMID: 31064388Full text available |
|
3 |
Material Type: Article
|
The COVID-19 Innovation SystemHealth affairs (Millwood, Va.), 2021-03, Vol.40 (3), p.400-5 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE Mar 2021 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.2020.02097 ;PMID: 33539184Full text available |
|
4 |
Material Type: Article
|
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitorsNature reviews. Drug discovery, 2018-11, Vol.17 (12), p.854-855 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 2018 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2018.210Full text available |
|
5 |
Material Type: Article
|
A minimal common outcome measure set for COVID-19 clinical researchThe Lancet infectious diseases, 2020-08, Vol.20 (8), p.e192-e197 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30483-7 ;PMID: 32539990Full text available |
|
6 |
Material Type: Article
|
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trialThe Lancet (British edition), 2020-05, Vol.395 (10237), p.1613-1626 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30932-6 ;PMID: 32580883Full text available |
|
7 |
Material Type: Article
|
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialThe Lancet infectious diseases, 2021-06, Vol.21 (6), p.803-812 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30987-7 ;PMID: 33548194Full text available |
|
8 |
Material Type: Article
|
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020-05, Vol.395 (10236), p.1569-1578 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31022-9 ;PMID: 32423584Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialThe Lancet Infectious Diseases, 2021-02, Vol.21 (2), p.181-192 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2021. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30843-4 ;PMID: 33217362Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
ShigellosisThe Lancet (British edition), 2018-02, Vol.391 (10122), p.801-812 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 24, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)33296-8 ;PMID: 29254859Full text available |
|
11 |
Material Type: Article
|
Computer-calculated compoundsNature (London), 2018-05, Vol.557 (7707), p.S55-S57 [Peer Reviewed Journal]Copyright Nature Publishing Group May 31, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-018-05267-xFull text available |
|
12 |
Material Type: Article
|
Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groupsBMC medicine, 2019-02, Vol.17 (1), p.47-47, Article 47 [Peer Reviewed Journal]COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s). 2019 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-019-1283-z ;PMID: 30808345Full text available |
|
13 |
Material Type: Article
|
Across Time: A Chronological Progression of Clinical Trials in IndiaCurēus (Palo Alto, CA), 2024-03, Vol.16 (3), p.e56786-e56786 [Peer Reviewed Journal]Copyright © 2024, Pathan et al. ;Copyright © 2024, Pathan et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2024, Pathan et al. 2024 Pathan et al. ;ISSN: 2168-8184 ;EISSN: 2168-8184 ;DOI: 10.7759/cureus.56786 ;PMID: 38650782Full text available |
|
14 |
Material Type: Article
|
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation MedicineMolecular therapy. Nucleic acids, 2017-09, Vol.8, p.132-143 [Peer Reviewed Journal]2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;2017. The Authors ;2017 The Authors 2017 ;ISSN: 2162-2531 ;EISSN: 2162-2531 ;DOI: 10.1016/j.omtn.2017.06.005 ;PMID: 28918016Full text available |
|
15 |
Material Type: Article
|
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 studyThe Lancet (British edition), 2016-02, Vol.387 (10019), p.679-690 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 13, 2016 ;2016. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)00803-X ;PMID: 26608256 ;CODEN: LANCAOFull text available |
|
16 |
Material Type: Article
|
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneityThe Lancet (British edition), 2018-09, Vol.392 (10150), p.880-890 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 8, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31767-7 ;PMID: 30215383Full text available |
|
17 |
Material Type: Article
|
Randomized Delayed-Start Trial of Levodopa in Parkinson’s DiseaseThe New England journal of medicine, 2019-01, Vol.380 (4), p.315-324 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1809983 ;PMID: 30673543Full text available |
|
18 |
Material Type: Article
|
Secondary Surgical Cytoreduction for Recurrent Ovarian CancerThe New England journal of medicine, 2019-11, Vol.381 (20), p.1929-1939 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1902626 ;PMID: 31722153Full text available |
|
19 |
Material Type: Article
|
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trialsThe Lancet (British edition), 2018-02, Vol.391 (10120), p.563-571 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 10, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)33106-9 ;PMID: 29217375Full text available |
|
20 |
Material Type: Article
|
The target landscape of clinical kinase drugsScience (American Association for the Advancement of Science), 2017-12, Vol.358 (6367), p.1148-1148 [Peer Reviewed Journal]Copyright © 2017 by the American Association for the Advancement of Science ;Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. ;Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.aan4368 ;PMID: 29191878Digital Resources/Online E-Resources |